Peo Cbrnd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that RHB-107 (upamostat)3 has been accepted for inclusion in the Austere environments Consortium for Enhanced Sepsis Outcomes' (ACESO) U.S. Government-supported PROTECT multinational platform trial for early COVID-19 outpatient treatment to be conducted in the U.S., Thailand, Ivory Coast and South Africa. The Company also announced that the Phase 2 study, predominantly funde ....

United Kingdom , Macau General , United States , Hong Kong , Adi Frish , Redhill Biopharma , Germany Heidelberg Pharmaceuticals , Program Executive Office For Chemical , Exchange Commission , Company Expanded Access Program , Department Of The Navy , Corporate Business Development , National Institutes Of Health Radiation , Department Of The Army , Redhill Biopharma Ltd , Nuclear Defense , Nuclear Countermeasures Program For Acute Radiation Syndrome , Consortium For Enhanced Sepsis Outcomes , Company Annual Report On Form , Department Of Defense , Military Medicine , Gilead Raday , Chief Operating Officer , National Institutes , Health Radiation , Nuclear Countermeasures Program ,